The study suggests that COVID-19-induced inflammation in the brain, specifically microglia, could lead to glio-vascular failure, a common contributor to various neurological abnormalities. The researchers developed an autopsy platform to integrate molecular anatomy, protein, and mRNA data from brain and peripheral organ samples. They found distinct mechanisms of microglial dysfunction associated with cerebral SARS-CoV-2 infection, including focal loss of microglial P2Y12R, dysregulated interactions, and mitochondrial failure.Infection-induced vascular inflammation in COVID-19 links focal microglial dysfunction with neuropathologies through IL-1/IL-6-related systemic inflammatory states | bioRxiv
***********
The COVID-19 pandemic has led to a public health crisis known as post-acute sequelae of COVID-19 (PASC). A study found increased neuroinflammation in PASC individuals compared to healthy controls. Additionally, peripheral blood plasma from PASC individuals showed positive correlations with circulating analytes related to vascular dysfunction. These findings suggest an interaction between neuroinflammation and vascular health may contribute to common symptoms of PASC. Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures | bioRxiv
************
Pericytes stabilize blood vessels, but pro-inflammatory conditions may expose perivascular cells to SARS-CoV-2. Engineered pericyte-supported capillaries showed higher extravasation and binding of spike protein in inflamed vessels, suggesting a potential COVID-19 vascular complications target. Vascular inflammation exposes perivascular cells to SARS-CoV-2 infection | bioRxiv
*************
A study comparing COVID-19 and neurologic complications found significant network-based relationships between the virus and neuroinflammation and brain microvascular injury pathways implicated in Alzheimer's disease (AD). The study also found aberrant expression of AD biomarkers in cerebrospinal fluid and blood of patients with COVID-19. While transcriptomic analyses showed low expression of SARS-CoV-2 entry factors in the human brain, neuroinflammatory changes were pronounced. The study suggests a possible role for brain microvascular injury in COVID-19-mediated cognitive impairment, with individuals with the AD risk allele showing reduced levels of antiviral defense genes. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment | bioRxiv

Comments
Post a Comment